New Chi­nese VC leads $10M round for a Har­vard spin­out look­ing to in­dus­tri­al­ize platelet man­u­fac­tur­ing

A new Chi­nese ven­ture group look­ing to bridge ther­a­peu­tics in­to the big Asian mar­ket led a $10 mil­lion start­up round for a Boston-based biotech up­start that is look­ing to in­dus­tri­al­ize the hu­man platelet-mak­ing process.

Spun out of the labs of Joseph Ital­iano and Jonathon Thon at Brigham and Women’s Hos­pi­tal and Har­vard, Platelet Bio­Gen­e­sis now has the cash to do the pre­clin­i­cal work on a new process to man­u­fac­ture platelets, rou­tine­ly used for can­cer pa­tients or af­ter surgery.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER